Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Q3 FY21 Earnings Presentation
28 slides from Navin Fluorine International's earnings presentation, Jan 25, 2021
Slide 1: Cover letter to stock exchanges
January 25, 2021 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (East), Mumbai 400001, India. Mumbai 400051, India. Stock Code: 532504 Stock Code: NAVINFLUOR EQ Dear Sir / Ma’am, Sub.: Investor Presenta
Slide 2: Investor Presentation – Q3 & 9M FY21
Navin Fluorine International Limited Investor Presentation – Q3 & 9M FY21
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: YoY Highlights 9MFY21 – Strong Performance
9MFY21 – Strong Performance High Value Business Operating Revenue Rs. 809 crores 525 396 +33% Operating EBITDA YoY Highlights 9MFY20 9MFY21 Rs. 228 crores 9MFY21 Margin at 28% 9MFY21 Revenue Contribution 65% Operating PBT Contribution from Rs. 197 crores High Value Businesses Margin at 24% High Valu
Slide 5: YoY Highlights Q3FY21 – Strong Performance
Q3FY21 – Strong Performance High Value Business Operating Revenue Rs. 297 crores 193 143 +35% Operating EBITDA YoY Highlights Q3FY20 Q3FY21 Rs. 82 crores Q3FY21 Margin at 28% Q3FY21 Revenue Contribution 65% Operating PBT Contribution from Rs. 72 crores High Value Businesses Margin at 24% High Value
Slide 6: Strong Profitable Growth
Strong Profitable Growth (Rs. Crs) High Value Business Legacy Business Total Revenue EBITDA margin is 28.2% for 9MFY21 up by 260 Bps Y-o-Y +33% +7% -22% 525 361 809 757 396 284 Strong momentum in High Value Business 9MFY20 9MFY21 9MFY20 9MFY21 9MFY20 9MFY21 performance continues Operating EBITDA Ope
Slide 7: Sustainable growth in High Value Business
Sustainable growth in High Value Business (Rs. Crs) Specialty Chemicals : Well balanced growth driven by Life Science and Crop Science segments 65% CRAMS : Strong customer traction and optimum capacity utilisation augurs well for future Contribution from High Value Specialty Business Unit CRAMS Busi
Slide 8: Business Vertical - Specialty Chemicals
Business Vertical - Specialty Chemicals Revenues (Rs. Crs) +27% +16% 122 322 277 97 Business has shown sustained growth on back of strong customer partnerships Leveraging our R&D capabilities and deep fluorination Q3FY20 Q3FY21 9MFY20 9MFY21 expertise to strengthen our new opportunities pipeline 41%
Slide 9: Business Vertical - CRAMS
Business Vertical - CRAMS Revenues (Rs. Crs) +52% +71% 71 204 47 119 Strong performance continues Improved enquiries and order flows from innovator pharma Q3FY20 Q3FY21 9MFY20 9MFY21 majors augurs well for sustainable future growth 0% Strengthened both demand generation and demand fulfilment parts o
Slide 10: Business Vertical - Inorganic Fluorides
Business Vertical - Inorganic Fluorides Revenues (Rs. Crs) +10% -14% 57 156 51 134 Performance improving quarter by quarter Q3FY20 Q3FY21 9MFY20 9MFY21 Widening of end user segments with new customer sign-ups 12% Sectors like stainless steel and glass are showing signs of recovery 9MFY21 88% India I
Slide 11: Business Vertical - Refrigerant Business
Business Vertical - Refrigerant Business Revenues (Rs. Crs) -27% -18% 57 205 47 150 Trade and service sectors slowly reviving Q3FY20 Q3FY21 9MFY20 9MFY21 Export volumes have shown good traction during the quarter Working on understanding the prospects of the next 53% generation of ref gases 47% 9MFY
Slide 12: Capacity Expansion - Multi-Purpose Plant (MPP)
Capacity Expansion - Multi-Purpose Plant (MPP) Capex to be funded Investing Rs. 195 crs will help commercialize new products in life science and crop science sectors in the through internal specialty chemicals business accruals & debt Through wholly Project will be executed through wholly owned subs
Slide 13: Capacity Expansion - High Performance Product (HPP)
Capacity Expansion - High Performance Product (HPP) Key Highlights Entered into a $410 million contract with a Global Company for manufacture and supply of a High-performance Product (HPP) in the fluorochemical space $410 Mn $61.5 Mn Project will be executed through wholly owned subsidiary Navin Flu
Slide 14: HPP Contract - Reinforcement of Trust
HPP Contract - Reinforcement of Trust Delivery on NFIL’s long term strategy with Developed new capabilities by venturing into important steps in portfolio transformation High Performance Product (HPP) Entered into seven-year contract of $410mn (i.e. approximately Rs. 2,800 crores) with a leading Glo
Slide 15: Business Strategy
N e PADMANABH MAFATLAL, GROUP BG Business Strategy How Navin Fluorine’s values have translated into business strengths....
Slide 16: Core Business Strategy
Core Business Strategy Increase share of our Presence into High- High Value Business demand specialized (CRAMS & Specialty) which product basket now contributes ~65% of the Topline Innovation & Change growth - Moving into the Customer’s clear new High-Performance choice - Strong pillar of Partnershi
Slide 17: Long Term Direction: Clear Focus on Core Business
Long Term Direction Clear Focus on Core Business Piramal Pharma and Navin Fluorine Mutually Agree on Piramal increasing its stake to 100% in Convergence Chemicals Navin Fluorine International Limited Piramal Group Focus area Focus area Continuing to grow its anesthetics Expanding High Value Business
Slide 18: Strategic Capital Re-allocation – Fully exit CCPL
Strategic Capital Re-allocation – Fully exit CCPL Rs. 65.1 Crores received for 49% Perpetual license to use the stake in CCPL + technical know-how for Rs. 7.9 Crores for leasehold rights development and marketing of select of the GIDC land earmarked for CCPL products Raw Material supply agreement wi
Slide 19: Financial Performance
N e PADMANABH MAFATLAL, GROUP Financial Performance Responsible Care”
Slide 20: Standalone Profitability Statement
Standalone Profitability Statement Particulars (Rs. Crs.) Q3 FY21 Q3 FY20 Y-o-Y % Q2 FY21 Q-o-Q % 9M FY21 9M FY20 Y-o-Y % Net Revenue from Operations 296.6 251.6 18% 307.7 -4% 809.1 757.2 7% Raw Material 135.9 107.1 136.7 357.7 344.0 Employee Expenses 29.4 29.3 28.3 86.7 81.9 Other Expenses 49.1 50.
Slide 21: Other Income Built-up
Other Income Built-up Q3 FY21 (Rs. Crs) Q3 FY20 (Rs. Crs) 9.1 11.0 -0.1 -0.9 -2.1 6.1 -6.3 4.6 Reported One Off Gain MTM Gain Adjusted Reported One Off Gain MTM Gain Adjusted Other Income Other Income Other Income Other Income 20 * One-Off Gain is towards Sale of Investments
Slide 22: Consolidated Profitability Statement
Consolidated Profitability Statement Particulars (Rs. Crs.) Q3 FY21 Q3 FY20 Y-o-Y % Q2 FY21 Q-o-Q % 9MFY21 9MFY20 Y-o-Y % Net Revenue from Operations 309.1 260.5 19% 318.9 -3% 843.0 785.0 7% Raw Material 142.5 111.2 143.2 376.7 358.1 Employee Expenses 36.2 33.0 34.0 104.8 95.6 Other Expenses 49.9 50
Slide 23: Consistent Dividend Performance
Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Special Dividend 550% ✓ Continuous Dividend over 10 years Final of 150% Interim + ✓ Special Dividend of 600% on FV of Special 150% Dividend Rs. 10 in FY12 of 75% 390% + 350% ✓ Special Divided of 75% on FV of Rs. Speci
Slide 24: NFIL at glance
9888 PADMANABH Ni MAFATLAL GROUP CH) NFIL at glance Responsible Care”
Slide 25: NFIL at glance
NFIL at glance Manufacturing plants strategically located closer to major ports Strong Clientele base in India & abroad, including Global Innovators Largest Integrated Specialty Fluorochemical Company in India Over 50 years of expertise in Handling Fluorine Built “India’s only plant with high pressu
Slide 26: Our Capabilities
Our Capabilities Manufacturing Raw Material Sourcing In-house R&D Fluorination Capabilities • Chemical Complex at Surat • Backward integration for Raw • State-of-the-art R&D centre – • Pioneered Manufacturing spread over 135 acres, houses material through 25% JV Navin Research Innovation of Refriger
Slide 27: Our Delivery
Our Delivery Commenced Specialty Commenced CRAMS Inorganic Fluorides & Refrigerants are Chemicals in 2000 business in 2011 traditional business since 1967 Specialty Chemicals – Inorganic Fluorides – FY20 – Revenue % CRAMS – 17% Refrigerants – 25% 37% 20% Specialty Chemicals – Inorganic Fluorides – R
Slide 28: Thank You Note
Thank You Note For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Ketan Sablok Mr. Jigar Kavaiya Chief Financial Officer +91 99206 02034 ket
Navin Fluorine International — Q3 FY21 Earnings Presentation on 6ix